Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

EMBC

Embecta Corp

Apr 23 • 04:00PM ET

10.88

Dollar change +0.16
Percentage change 1.49	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IJR VTI VB IWM VBR VXF FNDA IJS IWN VIG

Scroll to Statements

Index	RUT	P/E	11.33	EPS (ttm)	0.96	Insider Own	4.00%	Shs Outstand	57.33M	Perf Week	5.12%
Market Cap	626.47M	Forward P/E	4.92	EPS next Y	2.21	Insider Trans	0.09%	Shs Float	55.27M	Perf Month	-12.33%
Income	55.30M	PEG	-	EPS next Q	0.40	Inst Own	94.50%	Short Float	5.56%	Perf Quarter	-35.16%
Sales	1.12B	P/S	0.56	EPS this Y	-29.77%	Inst Trans	-2.10%	Short Ratio	7.13	Perf Half Y	-29.81%
Book/sh	-13.78	P/B	-	EPS next Y	5.36%	ROA	4.58%	Short Interest	3.07M	Perf Year	-63.07%
Cash/sh	5.19	P/C	2.10	EPS next 5Y	-	ROE	-	52W Range	9.93 - 32.00	Perf YTD	-42.53%
Dividend Est.	0.56 (5.14%)	P/FCF	-	EPS past 5Y	-	ROI	6.54%	52W High	-66.00%	Beta	0.80
Dividend TTM	0.60 (5.51%)	Quick Ratio	1.75	Sales past 5Y	0.35%	Gross Margin	66.55%	52W Low	9.62%	ATR (14)	0.49
Dividend Ex-Date	Feb 27, 2024	Current Ratio	2.20	EPS Y/Y TTM	-65.20%	Oper. Margin	18.91%	RSI (14)	35.93	Volatility	3.71% 3.90%
Employees	2200	Debt/Eq	-	Sales Y/Y TTM	0.58%	Profit Margin	4.93%	Recom	3.75	Target Price	16.50
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-43.30%	Payout	49.22%	Rel Volume	0.83	Prev Close	10.72
Sales Surprise	4.67%	EPS Surprise	34.07%	Sales Q/Q	0.58%	Earnings	Feb 09 BMO	Avg Volume	431.08K	Price	10.88
SMA20	-7.23%	SMA50	-17.01%	SMA200	-33.68%	Trades		Volume	357,508	Change	1.49%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$28
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight	$33
Jun-21-22	Initiated	BofA Securities	Underperform	$25

Apr-23-24 05:00PM	embecta to Report Fiscal Second Quarter 2024 Financial Results (GlobeNewswire)
Mar-06-24 06:00AM	embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes (GlobeNewswire)
Feb-10-24 08:55AM	Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-09-24 10:07PM	Q1 2024 Embecta Corp Earnings Call (Thomson Reuters StreetEvents) -8.47%
11:43AM	Why Embecta Stock Is Tanking Today (Motley Fool)
07:45AM	Loading…
07:45AM	Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:07AM	Embecta Corp (EMBC) Reports Modest Revenue Growth and Decline in Profitability in Q1 Fiscal 2024 (GuruFocus.com)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Feb-07-24 05:00PM	embecta to Participate in the 11th Annual BTIG MedTech Conference (GlobeNewswire)
Jan-24-24 05:00PM	embecta to Report Fiscal First Quarter 2024 Financial Results (GlobeNewswire)
Jan-21-24 08:33AM	16 Most Profitable New Stocks Today (Insider Monkey)
Jan-09-24 06:00AM	embecta Announces FDA 510(k) Submission for Insulin Patch Pump (GlobeNewswire)
Dec-14-23 05:00PM	embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-01-23 06:00AM	No embecta-made syringes impacted by FDA safety communication (GlobeNewswire)
05:13AM	Loading…
05:13AM	Embecta Corp's Dividend Analysis (GuruFocus.com)
Nov-29-23 05:00PM	embecta to Participate in Investor Conferences (GlobeNewswire)
Nov-22-23 09:34AM	Embecta Corp. (NASDAQ:EMBC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Nov-21-23 07:23AM	Embecta CEO Dev Kurdikar talks about growth expectations, GLP-1s (MedTech Dive)
07:15AM	Embecta Corp. (EMBC) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:13AM	Embecta Corp (EMBC) Posts Mixed Fiscal 2023 Results and Issues Fiscal 2024 Guidance (GuruFocus.com)
05:30AM	Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance (GlobeNewswire)
05:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Nov-14-23 10:00AM	Earnings Preview: Embecta Corp. (EMBC) Q4 Earnings Expected to Decline (Zacks) +7.29%
Oct-31-23 06:50AM	embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell (GlobeNewswire)
Oct-25-23 05:00PM	embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) -9.02%
Sep-28-23 08:10PM	7 Contrarian Stocks to Buy for the High-Stakes Gambler (InvestorPlace)
Sep-06-23 05:00PM	embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference (GlobeNewswire)
Aug-11-23 06:08AM	Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15 (Simply Wall St.)
Aug-08-23 10:19PM	Q3 2023 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
06:30AM	Loading…
06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2023 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Jul-11-23 05:00PM	embecta to Report Fiscal Third Quarter 2023 Financial Results (GlobeNewswire)
Jun-30-23 06:15AM	The Market Doesn't Like What It Sees From Embecta Corp.'s (NASDAQ:EMBC) Revenues Yet (Simply Wall St.)
Jun-21-23 08:00PM	EMBC: Lowering target price to $26.00 (Argus Research)
May-20-23 08:26AM	Just Four Days Till Embecta Corp. (NASDAQ:EMBC) Will Be Trading Ex-Dividend (Simply Wall St.)
May-15-23 05:38PM	UPDATE -- embecta to Participate in Investor Conferences (GlobeNewswire) -6.45%
05:00PM	embecta to Participate in Investor Conferences (GlobeNewswire)
09:30AM	Embecta Corp. (EMBC) Recently Broke Out Above the 50-Day Moving Average (Zacks)
09:30AM	Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
May-13-23 08:16AM	Embecta Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
12:05AM	Q2 2023 Embecta Corp Earnings Call (Thomson Reuters StreetEvents)
May-12-23 06:30AM	Embecta Corp. Reports Second Quarter Fiscal 2023 Financial Results (GlobeNewswire) +6.12%
06:15AM	embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
May-01-23 01:08PM	Embecta (EMBC) to Report Q2 Earnings: What's in Store? (Zacks)
Apr-26-23 08:00PM	EMBC: Lowering target price to $29.00 (Argus Research)
Apr-22-23 07:20AM	3 Top Dividend Kings to Buy for the Long Haul (Motley Fool)
Apr-21-23 06:15PM	Embecta Corp. (EMBC) Outpaces Stock Market Gains: What You Should Know (Zacks)
Apr-20-23 05:00PM	embecta to Report Fiscal Second Quarter 2023 Financial Results (GlobeNewswire)
Mar-26-23 08:45AM	3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential (Motley Fool)
Mar-22-23 06:46AM	Investors in Embecta (NASDAQ:EMBC) from a year ago are still down 25%, even after 3.5% gain this past week (Simply Wall St.) -5.70%
Mar-10-23 10:32AM	3 Medical Services Stocks to Buy Amid Industry Challenges (Zacks)
Feb-24-23 10:00AM	Best Momentum Stocks to Buy for February 24th (Zacks)
05:50AM	Best Value Stocks to Buy for February 24th (Zacks)
Feb-22-23 05:00PM	embecta sponsors educational symposium at ATTD 2023 (GlobeNewswire)
Feb-16-23 07:28AM	Daily Vickers Top Buyers & Sellers for 02/16/2023 (Argus Research) -5.28%
Feb-15-23 04:53PM	Embecta Corp. (NASDAQ:EMBC) Q1 2023 Earnings Call Transcript (Insider Monkey)
05:32AM	Embecta Corp.'s (NASDAQ:EMBC) Intrinsic Value Is Potentially 45% Above Its Share Price (Simply Wall St.)
Feb-14-23 06:54PM	Why Embecta Stock Popped by Nearly 13% Today (Motley Fool) +12.56%
12:08PM	Embecta Shares Gain As Q1 Earnings Exceed Expectations (Benzinga)
06:30AM	Embecta Corp. Reports First Quarter Fiscal 2023 Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Feb-08-23 05:00PM	embecta to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-30-23 01:25PM	10 Recent Spin-off Companies That Hedge Funds Are Piling Into (Insider Monkey)
Jan-25-23 07:00AM	embecta opens new global headquarters in Parsippany, N.J. (GlobeNewswire) +6.37%
Jan-24-23 05:00PM	embecta to Report Fiscal First Quarter 2023 Financial Results (GlobeNewswire)
Jan-21-23 06:16PM	12 52-Week Low Dividend Stocks To Consider (Insider Monkey)
Dec-20-22 11:34AM	Why Embecta Stock Is Sinking Today (Motley Fool) -15.64%
10:29AM	Embecta Stock Tumbles On Mixed Q4 Results, Softer Guidance (Benzinga)
06:30AM	Embecta Corp. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results (GlobeNewswire)
06:00AM	embecta Announces Quarterly Cash Dividend (GlobeNewswire)
Dec-14-22 05:00PM	embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-08-22 10:03AM	Top Investors Stock Portfolio: 10 Small-Cap Stocks to Buy (Insider Monkey)
Nov-07-22 06:50AM	Intuity Medical and embecta Launch Commercial Collaboration, Expanding Access to Self-Management Innovations for People With Diabetes (GlobeNewswire)
Nov-03-22 05:00PM	embecta to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results (GlobeNewswire)
Nov-01-22 06:50AM	embecta to Recognize National Diabetes Awareness Month by Ringing Nasdaq Opening Bell (GlobeNewswire)
Sep-16-22 04:30PM	Top Pharmaceutical Stocks for Q4 2022 (Investopedia)
Sep-14-22 06:00AM	3 Hidden Gem Stock Picks to Beat the September Market Slump (InvestorPlace)
Aug-18-22 05:00PM	embecta to Participate in Upcoming Investor Conferences in September (GlobeNewswire)
Aug-15-22 06:30AM	Embecta Corp. Reports Third Quarter Fiscal 2022 Financial Results (GlobeNewswire) +16.53%
06:00AM	embecta Announces Inaugural Quarterly Cash Dividend (GlobeNewswire)
Aug-05-22 09:01AM	Here's What Embecta Corp.'s (NASDAQ:EMBC) Shareholder Ownership Structure Looks Like (Simply Wall St.)
Jul-05-22 05:00PM	embecta Announces Earnings Conference Call Information for the Third Quarter of Fiscal Year 2022 (GlobeNewswire)
Jun-29-22 12:06PM	Top Healthcare Stocks for July 2022 (Investopedia)
May-13-22 06:30AM	Embecta Corp. Reports Second Quarter and First Six Months of Fiscal Year 2022 Financial Results and Provides Financial Guidance for the Last Six Months of Fiscal Year 2022 (GlobeNewswire) -8.83%
May-09-22 04:05PM	embecta to Participate in Upcoming Investor Conferences in May (GlobeNewswire)
Apr-19-22 06:50AM	embecta Announces Second Quarter 2022 Earnings Conference Call Information (GlobeNewswire)

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Melcher David F	Director	Feb 12 '24	Buy	16.25	2,000	32,500	45,080	Feb 12 07:08 PM
Melcher David F	Director	Sep 08 '23	Buy	15.77	6,233	98,271	27,698	Sep 08 09:47 PM
Kurdikar Devdatt	President and CEO	Aug 10 '23	Buy	21.81	5,000	109,050	244,791	Aug 10 05:11 PM
Mann Jeffrey Z	SVP, GC, Head Corp. Dev., Secy	Aug 10 '23	Buy	21.67	4,700	101,849	55,333	Aug 10 05:10 PM
Elguicze Jacob	SVP and CFO	Aug 10 '23	Buy	21.66	4,625	100,195	66,027	Aug 10 05:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EMBC

Embecta Corp

Upgrade your FINVIZ experience